Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jodi, Feser"'
Autor:
Carly M. Bliss, Raffael Nachbagauer, Chiara Mariottini, Frans Cuevas, Jodi Feser, Abdi Naficy, David I. Bernstein, Jeffrey Guptill, Emmanuel B. Walter, Francesco Berlanda-Scorza, Bruce L. Innis, Adolfo García-Sastre, Peter Palese, Florian Krammer, Lynda Coughlan
Publikováno v:
EBioMedicine, Vol 104, Iss , Pp 105153- (2024)
Summary: Background: The development of a universal influenza virus vaccine, to protect against both seasonal and pandemic influenza A viruses, is a long-standing public health goal. The conserved stalk domain of haemagglutinin (HA) is a promising va
Externí odkaz:
https://doaj.org/article/c9ca6df22ec740d499055ef8fed469f9
Autor:
K. Zaman, Md. Yunus, Asma B. Aziz, Jodi Feser, Jessica Mooney, Yuxiao Tang, Damon W. Ellison, Butsaya Thaisomboonsuk, Lei Zhang, Kathleen M. Neuzil, Anthony A. Marfin, G. William Letson
Publikováno v:
Vaccine: X, Vol 10, Iss , Pp 100143- (2022)
Introduction: Japanese encephalitis (JE) virus is one of the leading causes of viral encephalitis across temperate and tropical zones of Asia. The live attenuated SA 14-14-2 JE vaccine (CD-JEV) is one of three vaccines prequalified by the World Healt
Externí odkaz:
https://doaj.org/article/4ecce02de4074d5ebfea3788671a6284
Autor:
Maria Rosario Capeding, Edison Alberto, Jodi Feser, Jessica Mooney, Yuxiao Tang, Susette A. Audet, Judy A. Beeler, Damon W. Ellison, Lei Zhang, G. William Letson, Kathleen M. Neuzil, Anthony A. Marfin
Publikováno v:
Vaccine: X, Vol 6, Iss , Pp 100074- (2020)
Introduction: Japanese encephalitis (JE) virus is the leading cause of viral encephalitis across temperate and tropical zones of Asia. The live attenuated SA 14-14-2 JE vaccine (CD-JEV) is one of three vaccines prequalified by the World Health Organi
Externí odkaz:
https://doaj.org/article/4190104c27284ba4b3253b93b107d1c9
Autor:
J. Erin Staples, G. William Letson, Anthony A Marfin, Jodi Feser, Alex Van Keulen, Susan L. Hills, Aaron C. Brault, Amanda J. Panella
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Japanese encephalitis (JE) is a vaccine-preventable, mosquito-borne disease. Substantial progress with JE control in Asia has been made during the past decade, with most endemic countries now having JE vaccination programs, commonly using live attenu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e82af8ecc2d97b28564741de1b961ab3
https://doi.org/10.4269/ajtmh.20-1132
https://doi.org/10.4269/ajtmh.20-1132
Autor:
Peter Palese, Anna-Karin E. Palm, Patrick C. Wilson, Marie Van der Wielen, Rahnuma Wahid, Michelle Dickey, Jeffrey T. Guptill, Rong Hai, Chris Gast, Haley L. Dugan, David I. Bernstein, Alicia Solórzano, Abdollah Naficy, Christopher T. Stamper, Monica M. McNeal, Raffael Nachbagauer, Min Gao, Emmanuel B. Walter, Linda Yu-Ling Lan, Randy A. Albrecht, Dustin G. Shaw, Florian Krammer, Micah E. Tepora, Jodi Feser, Heather Wenzel, Megan E Ermler, Jenna J. Guthmiller, D. Freeman, Bruce L Innis, Adolfo García-Sastre, Carine Claeys, Kristen N Buschle, Weina Sun, Teddy John Wohlbold, Carole Henry, Victoria Sutton, Francesco Berlanda-Scorza, Yao-Qing Chen
Publikováno v:
The Lancet. Infectious Diseases
The Lancet. Infectious diseases, vol 20, iss 1
The Lancet. Infectious diseases, vol 20, iss 1
Summary Background Influenza viruses cause substantial annual morbidity and mortality globally. Current vaccines protect against influenza only when well matched to the circulating strains. However, antigenic drift can cause considerable mismatches b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a0aaf8f19fab8daf9145b012346dd89
http://europepmc.org/articles/PMC6928577
http://europepmc.org/articles/PMC6928577
Autor:
Jessica Mooney, Judy A. Beeler, Lei Zhang, Susette Audet, Maria Rosario Capeding, Kathleen M. Neuzil, Damon W. Ellison, Jodi Feser, Edison Alberto, Yuxiao Tang, G. William Letson, Anthony A. Marfin
Publikováno v:
Vaccine: X
Vaccine: X, Vol 6, Iss, Pp 100074-(2020)
Vaccine: X, Vol 6, Iss, Pp 100074-(2020)
Highlights • Live, attenuated SA 14-14-2 JE vaccine is immunogenic when given with MMR vaccine. • Live, attenuated SA 14-14-2 JE vaccine is safe when given with MMR vaccine. • Live, attenuated SA 14-14-2 JE vaccine may be coadministered with MM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::032af943e7239b1dbeb55bb06b372969
http://europepmc.org/articles/PMC7509462
http://europepmc.org/articles/PMC7509462
Autor:
Abdollah Naficy, Meagan McMahon, Emmanuel B. Walter, Jodi Feser, Florian Krammer, Disha Bhavsar, David I. Bernstein, Monica M. McNeal, Carine Claeys, Patrick C. Wilson, Alec W. Freyn, Alicia Solórzano, Veronika Chromikova, Juan Manuel Carreño, Chris Gast, Raffael Nachbagauer, Shirin Strohmeier, Peter Palese, Andres Javier, Carly M. Bliss, Jeffrey T. Guptill, Bruce L Innis, Teresa Aydillo, Daniel Stadlbauer, Adolfo García-Sastre, Marie Van der Wielen, Kaijun Jiang, Franceso Berlanda-Scorza, Lynda Coughlan, Weina Sun, Chiara Mariottini, Mohammad Amin Behzadi, Christina Capuano
Publikováno v:
Nature medicine. 27(1)
Seasonal influenza viruses constantly change through antigenic drift and the emergence of pandemic influenza viruses through antigenic shift is unpredictable. Conventional influenza virus vaccines induce strain-specific neutralizing antibodies agains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96f209222d6b16af0557867f82c814c7
https://pubmed.ncbi.nlm.nih.gov/33288923
https://pubmed.ncbi.nlm.nih.gov/33288923
Autor:
Aldiouma Diallo, Niranjan Kanesa-thasan, Sathie Cheikh, Kathleen M. Neuzil, Moussa Ndiaye, Djibril Diene, Jodi Feser, Kathryn E. Lafond, John C. Victor, Tofene Ndiaye, Marc-Alain Widdowson, Justin R. Ortiz, Bou Diarra, Assane Ndiaye
Introduction Effective, programmatically suitable influenza vaccines are needed for low-resource countries. Materials and methods This phase II, placebo-controlled, randomized safety and immunogenicity trial (NCT01819155) was conducted in Senegal usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6efc066d51ea0e7f943107815f88e462
https://europepmc.org/articles/PMC6327321/
https://europepmc.org/articles/PMC6327321/
Autor:
Kathleen M. Neuzil, Moshtaq Ahmed, Doli Goswami, Mohammed Ziaur Rahman, Kristen D.C. Lewis, Mustafizur Rahman, Justin R. Ortiz, Amina Tahia Sharmeen, W. Abdullah Brooks, Jodi Feser
Publikováno v:
Vaccine. 33:3415-3421
IntroductionLive-attenuated influenza vaccines (LAIVs) have the potential to be affordable, effective, and logistically feasible for immunization of children in low-resource settings.Material and methodsWe conducted a phase II, randomized, double-bli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdd0249ed21a61701134d3e6f6d197ab
https://doi.org/10.1016/j.vaccine.2015.04.048
https://doi.org/10.1016/j.vaccine.2015.04.048
Autor:
Elizabeth, Rotrosen, K, Zaman, Jodi, Feser, Justin R, Ortiz, Doli, Goswami, Amina Tahia, Sharmeen, Mustafizur, Rahman, Kristen D C, Lewis, Md Ziaur, Rahman, Burc, Barin, W Abdullah, Brooks, Kathleen M, Neuzil
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
In a live attenuated influenza vaccine (LAIV) trial among young Bangladeshi children, we found no presenting combinations of clinical signs and/or symptoms that could distinguish influenza virus infection from other acute respiratory infections. LAIV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d32e539109631da3f1408176ba2d1e09
https://pubmed.ncbi.nlm.nih.gov/29028980
https://pubmed.ncbi.nlm.nih.gov/29028980